Ilumetri 100 mg/1 ml, Injektionslösung
7680667840015
CH-66784
L04AC17
07.15.0.
Reimbursement limitations:
ILUMETRI3
Psoriasis en plaque sévères:
Traitement de patients adultes atteints de formes sévères de psoriasis en …
1 / 3
google
Details
- Product number
- 6678401
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- tildrakizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Ilumetri 100 mg/1 ml, Injektionslösung
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Almirall AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 66784
- Drug name
- Ilumetri, Injektionslösung
- Galenic form
- INLFS
- ATC Code
- L04AC17
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ILUMETRI sol inj 100 mg/ml 2 ser pré 1 ml
- Description (DE)
- ILUMETRI Inj Lös 100 mg/ml 2 Fertspr 1 ml
- Narcotic (BTM)
- No